ISSN: 2640-2637
Authors: Cauwenberghe CV*
The advent of stem cells reprogramming commenced with the discovery of the differentiation factors that allow the creation of human iPSCs (hiPSCs). Today, researchers all around the world are strongly committed to develop novel methods to design and build human stem cells in order to meet the increasing demand for more efficient production systems and manufacturing methods of stem cells for potential investigation into disease management. This trend is emphatically envisaged to accelerate the development of both regenerative medicine and drug discovery and development.
Keywords: Regenerative Medicine; Stem Cells; Gene Editing; Cell Reprogramming; Cell Therapy; Gene Therapy; Three Dimensional Bioprinting; Nanotechnology; Induced Pluripotent Stem Cells; Tissue Engineering